...
首页> 外文期刊>Applied Microbiology and Biotechnology >Engineered biosynthesis of 16-membered macrolides that require methoxymalonyl-ACP precursors in Streptomyces fradiae
【24h】

Engineered biosynthesis of 16-membered macrolides that require methoxymalonyl-ACP precursors in Streptomyces fradiae

机译:工程化合成16成员大环内酯类药物,需要在链霉菌中使用甲氧基丙二酰-ACP前体

获取原文
获取原文并翻译 | 示例

摘要

Development of host microorganisms for heterologous expression of polyketide synthases (PKS) that possess the intrinsic capacity to overproduce polyketides with a broad spectrum of precursors supports the current demand for new tools to create novel chemical structures by combinatorial engineering of modular and other classes of PKS. Streptomyces fradiae is an ideal host for development of generic polyketide-overproducing strains because it contains three of the most common precursors-malonyl-CoA, methylmalonyl-CoA and ethylmalonyl-CoA-used by modular PKS, and is a host that is amenable to genetic manipulation. We have expanded the utility of an overproducing S. fradiae strain for engineered biosynthesis of polyketides by engineering a biosynthetic pathway for methoxymalonyl-ACP, a fourth precursor used by many 16-membered macrolide PKS. This was achieved by introducing a set of five genes, fkbG-K from Streptomyces hygroscopicus, putatively encoding the methoxymalonyl-ACP biosynthetic pathway, into the S. fradiae chromosome. Heterologous expression of the midecamycin PKS genes in this strain resulted in 1 g/l production of a midecamycin analog. These results confirm the ability to engineer unusual precursor pathways to support high levels of polyketide production, and validate the use of S. fradiae for overproduction of 16-membered macrolides derived from heterologous PKS that require a broad range of precursors.
机译:具有聚酮化合物合酶(PKS)异源表达的宿主微生物的开发具有固有的能力,可以利用多种前体来过量生产聚酮化合物,这支持了对新工具的需求,这些新工具需要通过模块化和其他类别的PKS的组合工程来创建新颖的化学结构。链霉菌是开发通用聚酮化合物过量菌株的理想寄主,因为它包含三种最常见的前体-丙二醛-辅酶A,甲基丙二酰辅酶A和乙基丙二酰辅酶A-由模块化PKS使用,并且是适合遗传的宿主操纵。通过工程化许多16元大环内酯PKS使用的第四种前体甲氧基丙二酰-ACP的生物合成途径,我们扩大了过量生产的弗拉迪链霉菌菌株用于工程化合成聚酮化合物的效用。这是通过将五个基因,即吸水链霉菌的fkbG-K,假定编码甲氧基丙二酰-ACP生物合成途径,引入到S. fradiae染色体中来实现的。在该菌株中,米德霉素PKS基因的异源表达导致米德霉素类似物的产量为1 g / l。这些结果证实了工程化异常的前体途径以支持高水平的聚酮化合物生产的能力,并验证了利用苦链霉菌来过量生产衍生自需要多种前体的异源PKS的16元大环内酯类药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号